Pucotenlimab Combined with Lenvatinib

DRUG2 trials

Sponsors

Sun Yat-sen University, Fujian Medical University

Conditions

Gastric (Stomach) CancerRenal Cell Carcinoma

Early Phase 1

Clinical Efficacy of Pucotenlimab Combined With Lenvatinib and SOX Versus SOX Alone in Patients With HER2-Negative Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

Enrolling by invitationNCT07356466

Fujian Medical UniversityGastric (Stomach) Cancer

Start: 2025-05-01End: 2030-04-30Target: 100Updated: 2026-01-21

Phase 2

Pucotenlimab Combined With Lenvatinib as a Neodjuvant Therapy for Non Clear Cell Renal Cell Carcinoma

Sun Yat-sen UniversityRenal Cell Carcinoma

Start: 2023-11-11End: 2025-12-31Target: 47Updated: 2023-11-13